CrossPoint Therapeutics
Giheung
About CrossPoint Therapeutics
CrossPoint Therapeutics is a therapeutics company that specializes in drug development by using Stealth-Body with antibody source technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.0M
- Funding stage: Seed
- Last round: Seed (Mar 2026)
- Website: crosspointrx.comko
- Phone: +82 031-378-3575
Industries & Categories
Medical, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/crosspoint-therapeutics-104317 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.